All False Claims Act articles – Page 6
-
ArticleAlleged compliance failures at Omnicare lead to healthcare fraud lawsuit
A series of alleged compliance failures at pharmaceutical services provider Omnicare has resulted in the Department of Justice intervening in yet another civil healthcare fraud lawsuit against the company.
-
ArticleAvanir to pay $116M for engaging in kickback scheme
Avanir Pharmaceuticals will pay a combined $116 million in civil and criminal penalties for paying kickbacks to a physician to induce prescriptions of its drug Nuedexta, the Department of Justice announced.
-
ArticleMallinckrodt to pay $15.4M over kickback allegations
Pharmaceutical company Mallinckrodt is set to pay $15.4 million to the Justice Department to resolve allegations of illegal kickbacks to doctors in the form of lavish dinners and entertainment.
-
Article
American Airlines to pay $22.1M over falsified mail delivery allegations
American Airlines has agreed to pay $22.1 million to resolve allegations of violations of the False Claims Act regarding the reporting of international delivery times.
-
ArticleCisco’s $8.6M settlement for security flaws has broader ramifications
Cisco has reached an $8.6 million settlement for knowingly selling video surveillance software with critical security vulnerabilities. It’s believed to be the first cyber-security whistleblower case of its kind successfully litigated under the False Claims Act.
-
ArticleNovartis sets aside $700M in kickback case
Swiss pharmaceutical drug maker Novartis announced it has set aside $700 million for a potential settlement in a long-running lawsuit over allegations that the company paid hundreds of millions of dollars in kickbacks to doctors to induce them into prescribing drugs to patients to boost their sales.
-
VideoClaire McCusker Murray on DOJ's compliance view
Justice Department Principal Deputy Associate Attorney General Claire McCusker Murray kicks off Compliance Week’s 2019 annual conference with a keynote discussing the Department’s emphasis on corporate enforcement policy and promotion and incentivization of corporate compliance. She also sheds light on recent reforms to the False Claims Act.
-
Article
Informatica to pay $21.57M in False Claims Act case
The Department of Justice says Informatica will pay over $21 million stemming from a False Claims Act investigation.
-
ArticleJustice Department: How to receive cooperation credit in False Claims Act cases
New Justice Department guidance details how companies can be rewarded for assisting in a False Claims Act investigation, but it includes some caveats.
-
ArticleAstellas, Amgen to pay $124.75M for False Claims Act violations
Pharmaceutical companies Astellas and Amgen will pay a total of $124.75 million to resolve allegations that they violated the False Claims Act by illegally paying the Medicare co-pays for their own high-priced drugs.
-
Article
Covidien to pay $17.5M for False Claims Act violations
Covidien has agreed to pay $17.5 million for violations of the False Claims Act by providing free or discounted practice development and market development support to physicians in California and Florida to induce purchases of Covidien products, the Department of Justice announced.
-
Article
An inside look at False Claims Act enforcement
Deputy Associate Attorney General Stephen Cox in remarks this week offered some key insight into the Department of Justice’s enforcement principles, policies, and perspectives that guide its False Claims Act enforcement.
-
ArticleDistilling compliance lessons from healthcare fraud cases
False Claims Act recoveries related to healthcare fraud in fiscal year 2018 offer key insight into the best practices the government expects to ensure compliance with federal healthcare laws.
-
Blog
AmerisourceBergen to pay $625M over illegally repackaged drugs
AmerisourceBergen and its subsidiaries have agreed to pay $625 million to resolve its civil liability to the United States under the False Claims Act for causing false claims for the drugs it repackaged to be submitted to federal health care programs.
-
Blog
Mylan will pay $465 million to resolve False Claims Act liability
Mylan, maker of the EpiPen, has agreed to pay $465 million to settle Department of Justice allegations that it violated the False Claims Act by misclassifying the epinephrine injector as a generic drug to avoid paying Medicaid rebates.
-
Article
The Escobar decision, one year later
A year after the Supreme Court more closely defined materiality and implied consent in False Claims Act cases, compliance officers still have more questions than answers.
-
Article
Preventing False Claims Act liability
During a recent panel, federal and state officials, corporate defense attorneys, and whistleblower reps alike debated the ins and outs of U.S. FCA cases and how to defend them.
-
Blog
CA to pay $45M in False Claims Act case
CA, an information technology management software and services company, agreed to pay $45 million to resolve allegations under the False Claims Act that it made false statements and claims in the negotiation and administration of a General Services Administration contract, the Department of Justice announced.
-
Blog
Forest Labs to pay $38M for False Claims Act violations
Forest Laboratories and its subsidiary, Forest Pharmaceuticals, have agreed to pay $38 million to resolve allegations that they violated the False Claims Act by paying kickbacks to induce physicians to prescribe its drugs. Jaclyn Jaeger has more.
-
Blog
Omnicare to pay $28M to settle kickback allegations
Omnicare this week agreed to pay $28.1 million to resolve allegations that it solicited and received millions of dollars in kickbacks from drug maker Abbott Laboratories, the Justice Department announced. Jaclyn Jaeger has more.